Plerixafor 24 mg Injection
Plerixafor 24 mg Injection
Plerixafor 24 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Injection
Class: CXCR4 Chemokine Receptor Antagonist — Stem Cell Mobiliser
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Plerixafor 24 mg Injection is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This injection is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Stem cell mobilisation for autologous transplant in non-Hodgkin lymphoma
- Stem cell mobilisation for autologous transplant in multiple myeloma
- Used with G-CSF to improve stem cell collection by apheresis
Mechanism of Action
Plerixafor blocks the CXCR4 receptor on haematopoietic stem cells, preventing them from binding to SDF-1 (CXCL12) in the bone marrow. This releases stem cells into the bloodstream, where they can be collected by apheresis for transplantation.
Dosage & Administration
- Dosage of Plerixafor 24 mg Injection must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Diarrhoea and nausea
- Injection-site redness or swelling
- Tiredness and headache
- Joint pain or dizziness
- Raised white blood cell count
Contraindications
- Not for leukaemia; may mobilise leukaemic cells into blood
- Monitor blood counts; raised white cells and low platelets may occur
- Enlarged spleen and rare rupture; report left upper abdominal pain
- Pregnancy: may harm the foetus; use effective contraception
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Plerixafor Injection
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Plerixafor 24 mg. It is a haematopoietic stem cell mobiliser, used for stem cell mobilisation for autologous transplant in non-Hodgkin lymphoma and stem cell mobilisation for autologous transplant in multiple myeloma. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Plerixafor Injection under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Plerixafor Injection in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Plerixafor Injection in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Plerixafor Injection used for?
Plerixafor Injection is used for stem cell mobilisation for autologous transplant in non-Hodgkin lymphoma; stem cell mobilisation for autologous transplant in multiple myeloma; used with G-CSF to improve stem cell collection by apheresis. It should be used as advised by a registered medical practitioner.
Is Plerixafor Injection available for PCD pharma franchise on monopoly basis?
Yes. Plerixafor 24 mg Injection is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Plerixafor for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Plerixafor Injection under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Plerixafor Injection be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Plerixafor?
Plerixafor is a haematopoietic stem cell mobiliser (therapeutic class: CXCR4 Chemokine Receptor Antagonist — Stem Cell Mobiliser).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Plerixafor Injection?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Plerixafor 24 mg Injection?